key: cord-0734131-nqo90llp
authors: Fan, Bingwen Eugene; Shen, Jia Yi; Lim, Xin Rong; Tu, Tian Ming; Chang, Cheng Chieh Ray; Khin, Hnin Su Wai; Koh, Jasmine Shimin; Rao, Jai Prashanth; Lau, Soon Lee; Tan, Guat Bee; Chia, Yew Woon; Tay, Kay Yaw; Hameed, Shahul; Umapathi, Thirugnanam; Ong, Kiat Hoe; Prasad, Banumukala Madhava Rao Vishnu
title: Cerebral venous thrombosis post BNT162b2 mRNA SARS‐CoV‐2 vaccination: A black swan event
date: 2021-06-26
journal: Am J Hematol
DOI: 10.1002/ajh.26272
sha: e987bc3947fbab82cd57b8556783fcd997df716f
doc_id: 734131
cord_uid: nqo90llp

nan

, review existing data on the incidence and discuss mechanisms of CVT in BNT162b2 mRNA vaccination. vaccination itself may be associated with an increased risk of developing Covid-19-like disease or its complications 6 ". While the SARS-CoV-2 virus has a higher thrombogenic potential, the spike glycoprotein also carries significant thrombogenicity. We therefore postulate that the pathogenesis of BNT162b2 mRNA vaccine induced CVT may possibly be related to spike glycoprotein interaction causing immunothrombosis from 1) Disruption of endothelial homeostasis and the blood-brain bar- We propose that a combination of one or more conditions -a sufficiently high enough titre of spike glycoprotein in the circulation, coupled with a high number of activated platelets and aberrant complement activation by the spike glycoprotein -need to be present to cross the thrombotic threshold and trigger CVT. This may explain the rarity of this clinical observation. Further studies are required to determine the causal association of mRNA Covid-19 vaccines and CVT.

In conclusion, robust pharmacovigilance for Covid-19 vaccines is key in advancing global Covid-19 vaccination efforts with both speed and safety. However rare they may be, the reporting of adverse and black swan events such as Covid-19 vaccine-associated CVT is necessary to minimize uncertainty in the medical fraternity and the public, to increase awareness of regulatory authorities and clinicians to such events, so that these can be evaluated and managed promptly. Compared to most medications where adverse reactions that occurs in fewer than 1 in 10 000 are considered as "very rare", Covid-19 vaccines appear safe, given that risk of Covid-19 vaccine-associated CVT is by far much rarer than developing CVT in Covid-19 infection.

Thrombosis of the Cerebral Veins and Sinuses

Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase

Coronavirus vaccine -weekly summary of Yellow Card reporting

Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review

World Health Organization. COVID-19 vaccines: safety surveillance manual. World Health Organization

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

Summary of the public assessment report for Pfizer/BioNTech COVID-19 vaccine Updated 4

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

The authors greatly appreciate the efforts of our fellow healthcare workers and the support of their families during this pandemic.

The authors declare that they have no conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

B.E.F., J.Y.S., B.M.R.V.P. conceived the study. All authors were involved in patient care, and contributed substantially in the acquisition, analysis and interpretation of data, critical revision of manuscript for important intellectual content.

The study was approved by the Singapore Health Services institutional review board (CIRB 2020/2410). Waiver of consent was granted by the Singapore Health Services institutional review board.

The data that support the findings of this study are available from the